Therefore, in our study, we revealed that the expression levels of FAM72B are positively correlated with the levels of TMB, MSI, and NEO in most cancers, suggesting a possible higher response rate to ICIs among patients with high FAM72B expression. Here, FAM72B is linked to cancer.